Cannabis

Wednesday Apr 05, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Multiple Commercial Applications for Its Patented DehydraTECH(TM) Technology Platform

Lexaria Bioscience, a global innovator in drug delivery platforms, has developed and patented the DehydraTECH(TM) drug delivery platform technology The company has undertaken multiple studies as part of its extensive R&D program involving DehydraTECH, which continues to yield positive results This R&D program is focused on the development of product candidates across four main segments, which represent the platform’s potential commercial applications These segments include…

Monday Apr 03, 2023 - 11:15 am

Prime Harvest Inc. Launches Weed 4 The People Reg A+ Offering to Fund Cannabis Retail and Delivery Expansion Across California

Prime Harvest launched Reg A+ offering, Weed 4 The People, which enables public to invest for as little as $4.20 per share Company aims to raise $42M to fund expansion of JAXX Cannabis, flagship store and delivery platform Company achievements include 976% revenue growth from 2019-2022, 395% unique customer growth, 60+ brand partners Company aims to open 20++ locations across California within five years, recently…

Monday Apr 03, 2023 - 9:00 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) CEO, Chris Bunka, Confident that 2023 will be Lexaria’s Best Year Ever

Chris Bunka, Lexaria’s CEO, remains confident that 2023 will be Lexaria’s best year ever and has expressed his optimism that the company will continue to build its client base and increase its cash flows as the year progresses In his 2023 letter to stakeholders, the CEO expressed his satisfaction given that the company had delivered on a statement that he made the previous year, lauding…

Thursday Mar 30, 2023 - 11:15 am

NECANN Vermont Cannabis & Hemp Convention to Increase ROI in the Cannabis Industry

Cannabis entrepreneurs, executives, and marketers are invited to attend the NECANN Vermont Cannabis & Hemp Convention to be held from May 6-7, 2023 at Essex Junction, Burlington, VT. The fast-paced, energetic nature of cannabis and psychedelic events is prominent. NECANN specializes in creating resource hubs for the fast-expanding cannabis industry. Events where entrepreneurs, educators, businesses, advocates, investors, patients, and consumers can learn, connect, and thrive.…

Friday Mar 24, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Drug Delivery Technology Demonstrates Growing List of Potential Applications as Evidenced Through Numerous R&D Programs

DehydraTECH(TM) is suitable for use with a wide range of product formats, including pharmaceuticals, nutraceuticals, and over-the-counter capsules, pills, tablets, topicals, oral suspensions and more The patented technology increases the speed of onset, bioavailability, brain absorption, and reduces drug administration costs Lexaria currently has multiple R&D programs – yielding successful results and further opportunities for additional study models Lexaria Bioscience (NASDAQ: LEXX), a global innovator…

Tuesday Mar 21, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Tracking Proprietary Path to Drug Delivery Innovation and Commercialization on Robust RD Programs

Lexaria Bioscience is a global innovator in drug delivery platforms The company has been developing and commercializing patented DehydraTECH(TM), a technology that has been shown to increase the bioavailability of fat-soluble active molecules, improve the speed of onset and provide other benefits across multiple applications Lexaria has undertaken numerous R&D programs in an effort to build relationships with prospective corporate partners to out-license the technology…

Tuesday Mar 21, 2023 - 9:00 am

India Globalization Capital Inc. (NYSE American: IGC) Reports Triple-Digit Revenue Growth, Phase 2 Study Highlights in Q3 2023 Report

Net revenue increased 133% to $332,000 in the three months ended Dec. 31, 2022, the company reports Corporate highlights included expanded trial sites, enrollment for phase 2 IGC-AD1 study Commencement of study marks milestone in IGC’s progress toward gaining FDA approval for proprietary treatment In a fragile economic environment, the third-quarter 2023 financial results reported by India Globalization Capital (NYSE American: IGC) are particularly remarkable.…

Tuesday Mar 14, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Encouraged by Positive Findings from its DIAB-A22-1 Animal Model Study on Potential DehydraTECH-CBD(TM) Treatment for Diabetes

Lexaria’s DIAB-A22-1 animal model study just concluded, highlighting three positive outcomes, including an improvement in general activity, significant reductions in body weight, and improved triglyceride and cholesterol levels The study was undertaken by a third-party testing laboratory in Canada involving 24 obese and eight lean rats for a total of 32 male Zucker rats The success of this DIAB-A22-1 study marks a significant milestone for…

Friday Mar 10, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Additional Findings From Human Clinical Study, Demonstrating DehydraTECH(TM)-CBD Effects on Hypertension

The global antihypertensive drugs market was valued at around $20.5 billion in 2021 and is expected to reach $39.5 billion by 2030, growing at a CAGR of 2.95% Lexaria’s patented DehydraTECH(TM) technology is designed to formulate and deliver lipophilic drugs and active pharmaceutical ingredients (“APIs”), increasing effectiveness and improving how drugs are delivered into the bloodstream DehydraTECH is suitable for use with a wide range…

Tuesday Mar 07, 2023 - 10:30 am

India Globalization Capital Inc. (NYSE American: IGC) Focused on Fighting Alzheimer’s Disease with First-of-Kind Treatments in Study Phase

Government showing strong support for bills aimed at treating Alzheimer’s disease IGC’s leading drug candidate recently completed phase 1 of a safety and tolerability trial, and entered phase 2 Company’s proprietary treatments have “the potential to revolutionize the treatment of Alzheimer’s disease” Key legislation designed to fight Alzheimer’s has been introduced in Congress — or actually reintroduced: the NAPA Reauthorization Act was first introduced in…

Tuesday Mar 07, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX), a Global Innovator in Drug Delivery Platforms, Holds Discussions With Several Larger Companies on Path to Commercialization of DehydraTECH(TM) Technology

Lexaria’s patented DehydraTECH(TM) technology increases bioavailability, improving the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery, helping with speed of onset, and brain absorption of active pharmaceutical ingredients The company out-licenses the use of its patented DehydraTECH(TM) technology within the pharmaceutical industry and consumer sectors Lexaria has focused on applied R&D to establish areas of investigation for commercial pursuits,…

Thursday Mar 02, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Disrupt Drug Delivery Through Innovation

Lexaria's DehydraTECH(TM) technology has 28 granted patents, with many more patents pending worldwide DehydraTECH(TM) uses a patented formulation and dehydration process method to change how the body detects and absorbs drugs Lexaria is focusing on three main areas: CBD for hypertension, oral nicotine to replace vaping and smoking, and CBD potentially for diabetes and seizures Lexaria is conducting early work to support its FDA-registered IND…

Wednesday Mar 01, 2023 - 10:30 am

Prime Harvest Inc. Reveals That Their Reg A+ Equity Offering Has Been Granted Approval to Go Ahead

Prime Harvest recently revealed that the company’s Reg A+ equity offering has been greenlighted by the SEC The primary share offering will see the company market up to 10 million shares to investors at a price of $4.20 each, with estimated gross proceeds of $42 million The company has said that net proceeds will be destined towards the acquisition of licensed assets, continued expansion of…

Tuesday Feb 28, 2023 - 11:15 am

Alternative Products Expo at Ft. Lauderdale, Coming Up Soon

The Alternatives Products Expo, organized by ZJ Events is being held in Fort Lauderdale March 3-5, 2023. Exhibitors can showcase their products and market their innovative ideas in front of a large audience of potential investors. This premier counterculture show will feature a diverse range of products including CBD, DELTA-8, Nicotine Alternatives, Kratom, Extracts, Functional Beverages, and more. The Alternative Products Expo will offer participants…

Tuesday Feb 28, 2023 - 9:45 am

REZYFi, Inc. Delivers on Promise of Expertise, Focusing on Loan Origination and Support for Cannabis, High-risk Clients

Specialized mortgage lender REZYFi Inc. is strategically serving the needs of consumers and cannabis-related businesses through an alternative loan financing approach The company’s alternative mortgage financing strategy relies on real estate and other assets of the borrowers to secure loans for clients whose financial history or legal revenue base may make them unattractive borrowers for traditional banks The cannabis industry has long struggled to secure…

Monday Feb 27, 2023 - 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Additional HYPER-H21-4 Study Findings Offer Better Understanding of the Anti-Hypertensive Effects of DehydraTECH-CBD

Dosing for Lexaria’s ambitious and most comprehensive clinical study, HYPER-H21-4, was successfully completed in July 2022, with newly analyzed results now emerging Its latest findings bring the company closer to its upcoming FDA Phase 1b study while also explaining the patented DehydraTECH-(TM)-processed CBD interaction with the sympatho-chromaffin system via catestatin modulation Lexaria’s management is optimistic that DehyraTECH-CBD and its effectiveness in modulating catestatin levels could…

Thursday Feb 23, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking Forward to 2023 Goals for Patented DehydraTECH(TM) Technology

Lexaria’s 2022 R&D efforts saw high levels of success, establishing the company as one of the world’s leaders in the investigation of CBD for controlling human blood pressure and, separately, demonstrating performance enhancements compared to one of the world's leading anti-seizure medications During Q1 2023, Lexaria expects to provide additional results from its hypertension study HYPER-H21-4; complete dosing in the company’s animal dementia and diabetes…

Tuesday Feb 21, 2023 - 10:30 am

REZYFi, Inc. Stands Ready to Provide Much-Needed Capital to Cannabis Companies as Softening Mortgage Rates Boost Opportunities for Refinancing

REZYFi is a real estate-oriented mortgage company servicing the needs of licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies The average rate on a 30-year-fixed-rate mortgage, measured weekly, has been declining gradually since October last year, increasing the market for new and refinanced mortgages Mortgage refinancing can be a source of capital, presenting an important financing opportunity for…

Tuesday Feb 21, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Continues to Foster New Partnerships with its Expanding DehydraTECH(TM) Licensing Opportunities

Lexaria’s patented DehydraTECH(TM) technology improves how APIs enter the bloodstream through the promotion of healthier oral ingestion methods while also increasing the effectiveness of fat-soluble active molecules As a disruptive technology, its impact has been felt by other players in its space, leading Lexaria to open its doors to partnering with industry experts and implementing the technology across many fields, including licensing the technology to…

Wednesday Feb 15, 2023 - 9:45 am

REZYFi, Inc. Leveraging Everchanging Cannabis Landscape to Tap into Possible Legislation-Driven Growth for California Cannabis Industry

REZYFi is a real estate-oriented mortgage company that primarily targets licensed and permitted cannabis companies and owners of real estate who lease to cannabis companies The company is keen on capitalizing on possible opportunities brought by new and pending cannabis legislation Recently, the California Department of Cannabis Control sought the legal opinion of the state Attorney General’s office on whether or not interstate cannabis commerce…

Wednesday Feb 15, 2023 - 9:00 am

Prime Harvest Inc. Prepares to Expand Retail Footprint with Approval Recommendation From San Diego Planning Group

San Diego Planning Group grants approval recommendation to Prime Harvest Inc. to open retail cannabis outlet in Mount Hope Community planning groups often appeal retail cannabis applications, resulting in long delays, court cases, and project abandonment Prime Harvest received local support by meeting with community stakeholders, revealed plans to integrate community’s needs into project Prime Harvest is a member of the Community Alliance Program, provides…

Monday Feb 13, 2023 - 11:15 am

The 2023 New England Cannabis Convention: Unlocking the Full Spectrum of the Cannabis and Hemp Industry

The 2023 New England Cannabis Convention, a three-day event being conducted from March 10 – 12, 2023, invites cannabis professionals, investors, entrepreneurs, and growers, for immersive experiences and meaningful interactions. As the leading cannabis industry event on the east coast, NECANN brings new consumers and relationships to the attendees. The event regularly attracts the largest number of cannabis, MMJ, and hemp industry specialists, and this…

Monday Feb 13, 2023 - 10:30 am

Specialized Mortgage Loan Facilitator REZYFi, Inc. Represents Critical Capability for Hard-to-finance Cannabis Industry

Miami-based REZYFi Inc., is a mortgage lender that originates traditional loans but strategically is focused on non-traditional markets such as the cannabis industry The cannabis industry has enjoyed a boom in market interest but still needs a reliable loan source for real estate mortgages REZYFi’s strength as a commercial real estate lender is based on its licensing in the majority of states, with more to…

Friday Feb 10, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Expecting Additional Growth in 2023, Including IND Filing and IND Clinical Study

In addition to a recently released shareholder update letter from the company’s CEO, Chris Bunka, Lexaria Bioscience has now released a new investor presentation Despite 2022 inflationary conditions, Lexaria has seen growth company-wide – including hitting annual budgets +/- 2% over the last two years Lexaria’s patented DehydraTECH(TM) technology offers more effective delivery of active pharmaceutical ingredients into the bloodstream and brain tissue with 28…

Thursday Feb 09, 2023 - 9:00 am

REZYFi, Inc. Provides the Cannabis Industry with Critical Financing Options and Services Still Not Available with Traditional Banking Institutions

Cannabis businesses continue to face challenges finding opportunities for financing despite the continued drive for legalization REZYFi is pivotal providing much-needed support to the cannabis industry through two wholly owned subsidiaries – REZYFi Lending and ResMac Inc. For 2023, combined cannabis industry sales are projected to reach $38.8 billion In recent years, the cannabis industry has seen significant changes – with 39 states legalizing cannabis…

Wednesday Feb 08, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) – Technology Behind Patented Disruptive DehydraTECH(TM) Drug Delivery Platform

Lexaria has developed the DehydraTECH drug delivery technology, which enhances the performance of multiple categories of fat-soluble active molecules and drugs DehydraTECH has been shown to increase intestinal bioabsorption of certain bioactive compounds by as much as 27 times, with its onset of action being as little as 1.5 minutes The technology is also expected to lower the overall drug costs because it delivers more…

Tuesday Feb 07, 2023 - 10:30 am

REZYFi, Inc. Anticipates Increased Demand for its Services Following Rise in Mortgage Demand

30-year fixed-rate mortgages with conforming loan balances of $726,200 or less, saw rates decrease from 6.42% to 6.23% for the week ending January 18, 2023, resulting in a 28% increase in mortgage application volume, and a 34% increase in refinance demand It is projected that by the end of 2023, mortgage rates in the country will drop by 5.25%, coming from 2022, which saw home…

Monday Feb 06, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) To Intensify Focus on Commercial Execution of its DehydraTECH Technology for the 2023 Calendar year

2022 saw Lexaria introduce its patented DehydraTECH(TM) technology to world-leading collaborators while also exploring DehydraTECH-CBD for the potential treatment of hypertension It also saw success in its research for the potential treatment of conditions such as epilepsy, making the year Lexaria’s most active one yet Significant progress was made on key objectives in 2022, a feat which the company plans to capitalize on and leverage…

Friday Jan 27, 2023 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO Anticipating ‘Best Year Ever’ in 2023

Lexaria Bioscience recently released its 2023 annual letter from CEO Chris Bunka, providing a strategic update to all stakeholders The letter highlights the key milestones achieved in calendar 2022, outlines expectations for calendar 2023, and indicates why Chris Bunka expects 2023 to be the company’s best year so far 1In calendar 2023, Lexaria expects to attain FDA registration for an investigational new drug (“IND”) program…

Wednesday Jan 25, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Uses Patented DehydraTECH(TM) Technology to Increase Bioavailability to Meet Underserved Medical Needs

Bioavailability measures the amount of a substance that enters the bloodstream, with most oral routes providing lower amounts of the drug due to poor bioavailability Studies on nutrients show that not all the nutrients we ingest actually enter the bloodstream due to inhibiting factors in the digestive tract Lexaria’s patented DehydraTECH(TM) technology helps increase bioavailability for active pharmaceutical ingredients (“APIs”), which has been shown through…

Tuesday Jan 17, 2023 - 12:00 pm

India Globalization Capital Inc. (NYSE American: IGC) Announces Beginning of Phase 2 Clinical Trials for Proprietary Drug Candidate in Treating Alzheimer’s

Believed to be the first natural low-doses of THC-based compound to enter human trials for Alzheimer’s IGC-AD1 has the potential to revolutionize the treatment of Alzheimer’s disease The clinical trial is expected to produce data to “help us to further understand the metabolism of IGC-AD1 for a diverse population,” says CEO In a historic first, India Globalization Capital (NYSE American: IGC) has begun Phase 2…

Friday Jan 13, 2023 - 10:30 am

REZYFi, Inc. Creates Opportunities for Cannabis Related Real Estate Financing as Mainstream Media Begins to Show Growing Acceptance of Cannabis-Derived Products

Google will change its requirements for product ads on January 20, 2023, to allow the promotion of FDA-approved pharmaceuticals containing CBD and topical hemp-derived CBD products in California, Colorado, and Puerto Rico Non-FDA-approved CBD topicals will require certification from LegitScript, which will test THC compliance and review the third-party Certificate of Analysis of each product to be promoted With the growing acceptance of cannabis, REZYFi…

Wednesday Jan 11, 2023 - 11:15 am

REZYFi, Inc. Leverages Cannabis and Real Estate Financing Opportunities Through Wholly-Owned Subsidiaries

The growing perception is that cannabis companies investing in real estate raise the value of the area in which they invest A 2020 study conducted in states where medicinal and recreational cannabis is legal found that 35-36% of respondents saw an increase in demand for warehouses, 23% for storefronts, and up to 28% for land The global legal cannabis market was valued at $17.8 billion…

Wednesday Jan 11, 2023 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Adds to its Existing Suite of Global Patents with First Granted Patent in Canada

Lexaria has announced patent #3,093,414, its first patent in Canada, its 28th granted patent worldwide, and the first patent from its sixth patent family This patent joins the ranks of previously issued patents in Australia, India, Japan, and the EU, even as similar patent applications for skin-based delivery of patented DehydraTECH formulations remain pending in many countries In Lexaria’s 2018 study, DehydraTECH-processed CBD demonstrated almost…

Monday Jan 09, 2023 - 10:30 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM)-Processed CBD Can be Administered More Effectively at Lower Levels than Other CBD, Boosting Hope for Hypertension Patients

Lexaria, a global innovator in drug delivery platforms, has developed the patented DehydraTECH(TM) platform technology, which has been shown to increase the bio-absorption of various fat-soluble active molecules and drugs In a recently completed study, Lexaria showed that DehydraTECH-processed CBD had exceptional safety and tolerability profile in addition to resulting in a statistically significant lowering of 24-hour ambulatory blood pressure The company also reported that…

Friday Jan 06, 2023 - 11:15 am

Flora Growth Corp. (NASDAQ: FLGC) Acquisition of Franchise Global Health Completed, Rapid Jump in Potential for European Cannabis Sales

International cannabis operator Flora Growth Corp. is rapidly expanding its global footprint and Colombia-based international supply chain thanks to strategic acquisitions during the past several months Flora’s most recent acquisition was concluded just before Christmas on finalization of an agreement with multi-national operator Franchise Global Health Inc. that strengthens Flora’s position in Europe Franchise Global Health (“FGH”) serves 1,200 pharmacies in Germany, which the companies…

Wednesday Jan 04, 2023 - 11:15 am

Dosing Begins in Lexaria Bioscience Corp. (NASDAQ: LEXX) Human Clinical Study, Evaluating DehydraTECH(TM)-Nicotine Against Leading Nicotine Oral Pouch Brands

The 36-person human pharmacokinetic randomized, double-blind, cross-over study NIC-H22-1 will compare its patented DehydraTECH(TM)-nicotine to leading nicotine pouches On! and Zyn The white pouch oral delivery of nicotine is thought to avoid harmful lung outcomes that smokers and vapers experience The global nicotine pouch market was valued at $2.33 billion in 2020 and is expected to reach $21.84 billion by 2027, driven by an increase…

Wednesday Dec 28, 2022 - 12:45 pm

Lift Vancouver 2023 Dedicated to Uplifting the Cannabis Community In Canada

It’s time for cannabis industry leaders and enthusiasts in Canada, and across North America, to gather and refresh their cannabis knowledge and connections at Lift Vancouver 2023 taking place at the Vancouver Convention Centre from January 12-14, 2023. Lift is Canada’s #1 Cannabis Conference and Trade Show, engaged in curating and presenting quality cannabis content to audiences throughout the full cannabis ecosystem while establishing collaborative…

Wednesday Dec 28, 2022 - 10:30 am

USDA’s Inclusion of Hemp Data in the 2022 Census for Agriculture is seen as Another Boost to the Cannabis Sector, and REZYFi, Inc. is Set to Benefit from It

The USDA is set to include hemp data in its 2022 Census of Agriculture, another indication of the ongoing growth in support of the overall cannabis industry, benefitting related mortgage origination and financing company REZYFi, Inc. The legal marijuana industry is set to hit 53% in 2026, a 60% growth, with international legal marijuana sales expected to hit $130 billion by 2030 REZYFi is confident…

Wednesday Dec 28, 2022 - 9:00 am

M&A Activity Keeps Flora Growth Corp. (NASDAQ: FLGC) Revenues Strong Amid Expected Rebound in Cannabis Industry

Cannabis cultivator and international brand developer Flora Growth has continued to build its revenues through accretive acquisitions during the past year and expects to see revenues continue to rise amid further M&A activity Flora expects to lock in its latest acquisition by the end of the month after shareholders meet to discuss the proposed deal with multi-national operator Franchise Global Health (“FGH”), which would grant…

Articles

Articles Category: Cannabis

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions